Aranesp

EPO Pills: A Challenge For Amgen And Johnson & Johnson

EPO Pills: A Challenge For Amgen And Johnson & Johnson

Seeking Alpha

Did Someone Say Kickbacks? Amgen Pays $29M Over Aranesp Marketing

Did Someone Say Kickbacks? Amgen Pays $29M Over Aranesp Marketing

Pharmalot

Yet Another Negative Trial For Amgen's Aranesp

Yet Another Negative Trial For Amgen's Aranesp

Forbes

Amgen’s Aranesp for Anemia Fails to Help Heart Patients

Amgen’s Aranesp for Anemia Fails to Help Heart Patients

Bloomberg

Amgen whistleblower can't challenge $612M settlement, judge says

Amgen whistleblower can't challenge $612M settlement, judge says

Fierce Pharma

U.S. court approves Amgen's $762 mln payment in drug case

U.S. court approves Amgen's $762 mln payment in drug case

Reuters

Amgen’s Misbranding Case Resolution Delayed by U.S. Judge

Amgen’s Misbranding Case Resolution Delayed by U.S. Judge

Bloomberg

Amgen Pleads Guilty to Misbranding Anemia Drug Aranesp

Amgen Pleads Guilty to Misbranding Anemia Drug Aranesp

Bloomberg

Amgen says continues to see stabilization in Aranesp business by mid-year

Amgen says continues to see stabilization in Aranesp business by mid-year

The Fly on the Wall

Anemic Growth? Not From These Drugs.

Anemic Growth? Not From These Drugs.

Motley Fool